Comparative Evaluation of Antibacterial Activity of Probiotics SK12 and SM18: An In Vitro Study

Srihari Nirguna Chandrasekhar1, Shanthala B Mallikarjun1, Henna P Salim1

  • 1Department of Pediatric and Preventive Dentistry, Coorg Institute of Dental Sciences, Virajpet, Karnataka, India.

Abstract

Insights

Probiotic strain SM18 shows superior antimicrobial activity against Streptococcus mutans compared to SK12. SM18 is effective at lower concentrations, highlighting its potential in managing cariogenic bacteria.

Area of Science:

  • Oral microbiology
  • Probiotic research
  • Antimicrobial susceptibility testing

Background:

  • Streptococcus mutans is a primary etiological agent of dental caries.
  • Probiotics are being investigated for their potential to modulate oral microbiota and prevent caries.
  • This study evaluates the in vitro antimicrobial efficacy of two probiotic strains, SK12 and SM18, against S. mutans.

Discussion:

  • Both SK12 and SM18 probiotics exhibited antimicrobial activity against Streptococcus mutans.
  • SM18 demonstrated a larger zone of inhibition (20 mm) compared to SK12 (15 mm).
  • SM18 was bactericidal at a minimum concentration of 0.8 mg/mL, while SK12 required 1.6 mg/mL.

Key Insights:

  • Probiotic SM18 possesses stronger antibacterial properties against S. mutans than probiotic SK12.
  • Lower concentrations of SM18 are effective in inhibiting and killing S. mutans.
  • The findings support the targeted application of specific probiotic strains for caries prevention.

Outlook:

  • Further in vivo studies are warranted to confirm the clinical efficacy of SM18 in caries prevention.
  • Investigating the mechanisms of action of SM18 against S. mutans could provide deeper insights.
  • Optimizing probiotic formulations and delivery methods may enhance their therapeutic potential in oral health.